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Abstract
Background: Development of the valves and septa of the heart depends on the formation and remodeling of the
endocardial cushions in the atrioventricular canal and outflow tract. These cushions are populated by mesenchyme
produced from the endocardium by epithelial-mesenchymal transition (EMT). The endocardial cushions are remodeled
into the valves at post-EMT stages via differentiation of the mesenchyme and changes in the extracellular matrix (ECM).
Transforming growth factor β (TGFβ) signaling has been implicated in both the induction of EMT in the endocardial
cushions and the remodeling of the valves at post-EMT stages. We previously identified the RNA binding protein
muscleblind-like 1 (MBNL1) as a negative regulator of TGFβ signaling and EMT in chicken endocardial cushions ex
vivo. Here, we investigate the role of MBNL1 in endocardial cushion development and valvulogenesis in Mbnl1ΔE3/ΔE3
mice, which are null for MBNL1 protein.
Methods: Collagen gel invasion assays, histology, immunohistochemistry, real-time RT-PCR, optical coherence
tomography, and echocardiography were used to evaluate EMT and TGFβ signaling in the endocardial cushions, and
morphogenesis, ECM composition, and function of the heart valves.
Results: As in chicken, the loss of MBNL1 promotes precocious TGFβ signaling and EMT in the endocardial cushions.
Surprisingly, this does not lead to the production of excess mesenchyme, but later valve morphogenesis is aberrant.
Adult Mbnl1ΔE3/ΔE3 mice exhibit valve dysmorphia with elevated TGFβ signaling, changes in ECM composition, and
increased pigmentation. This is accompanied by a high incidence of regurgitation across both inflow and outflow
valves. Mbnl1ΔE3/ΔE3 mice also have a high incidence of ostium secundum septal defects accompanied by atrial
communication, but do not develop overt cardiomyopathy.
Conclusions: Together, these data indicate that MBNL1 plays a conserved role in negatively regulating TGFβ signaling,
and is required for normal valve morphogenesis and homeostasis in vivo.
Keywords: Muscleblind-like 1, Transforming growth factor β, Epithelial-mesenchymal transition, Endocardial cushions,
Heart valves, Mouse
Background
Valve defects are among the most common congenital
heart defects, and are associated with significant health
problems and mortality throughout life [1]. Their exact
incidence is unknown because many valve defects are
not diagnosed until adulthood [2]. Aortic valve defects
alone occur in 1-2 % of the population [3]. The preva-
lence of adults with valvular heart disease is increasing,
due to improved surgical treatments and increases in
lifespan that may be accompanied by valve degeneration
[4]. Congenital valve defects and adult valve disease may
not be distinct, since structural or biomechanical abnor-
malities in the valves may be present but not readily ap-
preciated at birth. The heart valves form by remodeling
embryonic structures called endocardial cushions. Out-
growth of the cushions occurs via localized expansion of
extracellular matrix (ECM) between the endocardium and
myocardium in the atrioventricular canal (AVC) and out-
flow tract (OFT), after which the cushions are cellularized
by invasion of a subpopulation of endocardial cells under-
going epithelial-mesenchymal transition (EMT) [5]. At
post-EMT stages, this cushion mesenchyme differentiates
into valve interstitial cells, specialized fibroblasts that
produce the highly stratified matrix of the mature valves
[2, 3]. The mitral and tricuspid valves form from the AVC
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endocardial cushions, while the aortic and pulmonary
valves arise from the OFT cushions [6].
Transforming growth factor β (TGFβ) signaling induces
endocardial cushion EMT in both birds and mammals, al-
though the roles of specific TGFβ paralogs differ [7–9]. In
chick, TGFβ2 is required for activation of the endocardial
cells, in which cell polarity and cell-cell contacts are lost,
and TGFβ3 is required for invasion of the transformed
mesenchymal cells into the cushion matrix [8, 9]. TGFβ1
is not expressed in the developing cushions. Both TGFβ2
and TGFβ3 are produced in the myocardium prior to the
onset of EMT, and TGFβ3 is found in the endocardium
during stages of active EMT [8, 10, 11]. Autocrine produc-
tion of TGFβ3 in the cushion endocardium is essential for
induction of invasive mesenchyme [11, 12]. In mouse,
TGFβ3 is not expressed in the heart until E11.5, well after
EMT is underway, and is restricted to the mesenchymal
cells of the cushions [13]. No cardiac malformations have
been found in Tgfb3-null mice [14, 15]. TGFβ2 has an
expression pattern in the mouse heart that is similar to
that of TGFβ3 in chick, and inhibition of TGFβ2 blocks
invasion in mouse AVC explants [13, 16]. Tgfb2-null mice
exhibit impaired EMT, hypocellular cushions, and a var-
iety of valve and septal defects [7, 17, 18]. Thus, in mouse
TGFβ2 plays a role orthologous to that of chick TGFβ3.
TGFβ1 is also expressed in mouse AVC endocardium, and
although it is not essential for endocardial cushion EMT
in vivo,Tgfb1-null mice have disorganized valves [19].
We previously identified a role for muscleblind-like 1
(MBNL1) in the regulation of TGFβ-dependent EMT in
the endocardial cushions in chick [20, 21]. MBNL1 is a
member of the MBNL family of RNA binding proteins
that regulate pre-mRNA alternative splicing, alternative
polyadenylation, microRNA biogenesis, mRNA stability
and localization [22–25]. We previously reported that
in the embryonic chicken heart MBNL1 transcripts are
found in the atrial and ventricular myocardium, and in
the endocardium of the AVC and OFT endocardial
cushions during EMT and immediately prior to its on-
set [20, 21]. We demonstrated that knockdown of
MBNL1 in chick AVC or OFT explants promotes inva-
sive mesenchyme formation ex vivo [20, 21]. This effect
is dependent upon TGFβ3, and is accompanied by pre-
cocious and elevated secretion of active TGFβ3 by the
endocardial cells [20, 21]. Early exposure to excess
TGFβ3 is sufficient to induce precocious and elevated
invasion in AVC explants [20]. These data suggested
that MBNL1 negatively regulates EMT in the endocar-
dial cushions by limiting the levels and timing of in-
ductive, autocrine TGFβ signaling.
In this study, we investigate the role of MBNL1 in
mouse endocardial cushion development and valvulo-
genesis. We demonstrate that high expression of
MBNL1 in the endocardial cushions is conserved in
mouse. Using Mbnl1ΔE3/ΔE3 mice, which are null for
MBNL1 protein, we show that loss of MBNL1 promotes
invasive mesenchyme production in AVC explants ex
vivo and precocious TGFβ signaling and EMT in the
AVC in vivo, but does not lead to an excess in total mes-
enchyme production. In the fetal Mbnl1ΔE3/ΔE3 heart,
however, valve morphogenesis is aberrant. In the adult
heart, Mbnl1ΔE3/ΔE3 mice continue to exhibit valve dys-
morphia, accompanied by elevated TGFβ signaling and
changes in ECM composition. Significant regurgitation
was observed across both inflow and outflow valves.
Mbnl1ΔE3/ΔE3 mice also have a high incidence of ostium
secundum atrial septal defects and increased valve pig-
mentation. Taken together, these data indicate that
MBNL1 is required for normal heart valve development
and function in vivo.
Results
MBNL1 is expressed in the endocardial cushions and
mature heart valves
To determine whether MBNL1 expression in the endo-
cardial cushions is conserved in mammals, we per-
formed immunohistochemistry on sections from mouse
hearts at different stages of development. As in the
chicken heart, MBNL1 was strongly detected in the
myocardium and AVC endocardium at E9, prior to the
onset of EMT (Fig. 1a, b). MBNL1 is broadly expressed
throughout the embryo, but is not ubiquitous; for ex-
ample, although MBNL1 protein is strongly detected in
the ectodermal linings it is low or absent in the inter-
ior cephalic tissues of the mid-, fore-, and hindbrain
(Additional file 1: Figure S1). At E11.5, when EMT is
well underway, intense nuclear MBNL1 staining was
observed in the endocardium and mesenchyme of the
AVC and OFT cushions (Fig. 1c, d). Strong nuclear
MBNL1 staining persists in the immature valves at
late fetal stages (Fig. 1f ) and in the mature valves of
the adult heart (Fig. 1g). MBNL1 was also seen in the
developing myocardium, where it is found in both the
nucleus and cytoplasm (Fig. 1c, e, f ). In the adult
myocardium, MBNL1 staining is more diffuse and
cytoplasmic (Fig. 1g), consistent with previous reports
that MBNL1 is more strongly detected in cytoplasmic
than nuclear extracts from whole hearts at postnatal
stages [26, 27].
By western blot, MBNL1 is expressed in adult heart
valves at levels comparable or higher than levels in the
chambers (Fig. 1h). Interestingly, slightly different
MBNL1 isoforms were detected in the different com-
partments of the heart, with the slowest migrating iso-
form in the valves and the fastest in the ventricles.
Alternative splicing of Mbnl1 transcripts can lead to
the generation of several different MBNL1 protein iso-
forms, ranging in size from 35 to 43 kDa [28]. We and
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Fig. 1 MBNL1 is highly expressed in the endocardial cushions and heart valves. Immunohistochemistry with an anti-MBNL1 antibody was
performed on sagittal sections from wild type mouse embryos (a-f) and coronal sections of adult hearts (g). Representative sections from
one of four embryos or one of two adult hearts are shown. a Close-up of the heart at E9 stained with the secondary antibody alone is
shown as a negative control. b Close-up of the heart at E9 shows expression of MBNL1 in the early myocardium and endocardium of
the nascent endocardial cushions just prior to the onset of EMT. c Close-up of the heart at E11.5 shows strong MBNL1 expression in the
endocardial cushions of the AVC and OFT. Higher magnification views of the boxed regions in the endocardial cushion (d) and the ventricular wall (e)
show intense nuclear staining in the cushion endocardial cells, but more diffuse staining in the myocardium. Intense nuclear MBNL1 staining persists
in the fetal valves at E19.5 (f) and mature heart valves (g), while MBNL1 remains more diffusely distributed in the nucleus and cytoplasm
in the myocardium. Asterisks highlight accumulations of melanin in the adult valve. h Western blot analysis confirms high MBNL1 expression in the
adult heart, and suggests different cardiac tissues may express different MBNL1 isoforms. Protein integrity and loading were assessed by Ponceau S
staining. A representative of three independent blots with similar results is shown. Atr = atrium, Vent = ventricle, EC = endocardial cushion,
OFT = outflow tract, TC = tricuspid valve, Val = heart valves
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others previously reported that inclusion or skipping of
exon 7 [28] affects the subcellular localization of
MBNL1 protein such that the larger exon-included
form is predominantly nuclear whereas the exon-
skipped form is both nuclear and cytoplasmic [29–31].
Although preferential inclusion of exon 7 in the heart
valves would explain both its strong nuclear localization
and its slower migration, we found that exon 7 is in
fact ~95 % skipped in adult mouse heart valves, atria,
and ventricles (data not shown).
Loss of MBNL1 has a transient stimulatory effect on EMT
in the endocardial cushions ex vivo
We previously demonstrated that knockdown of MBNL1
in chick H&H stage 14 AVC explants promotes invasive
mesenchyme production ex vivo, indicating that MBNL1
is a negative regulator of endocardial cushion EMT
[20, 21]. To determine if this role is conserved in mam-
mals, invasive mesenchyme production was compared in
AVC explants from wild type and Mbnl1ΔE3/ΔE3 hearts
(Fig. 2a-c). Indeed, E9 explants from Mbnl1ΔE3/ΔE3 mice
Fig. 2 Loss of MBNL1 stimulates EMT ex vivo in a stage-specific manner. Images of wild type (a, a’) or Mbnl1ΔE3/ΔE3 (b, b’) E9 AVC explant cultures
were taken in the plane of focus of the surface of the gel (a, b) and beneath the surface of the gel (a’, b’) to show invaded mesenchymal cells.
Filled arrowheads indicate cells in the focal plane, whereas open arrowheads indicate the same cells out of focus in a different plane. c AVC regions
from E9 or E9.5 wild type or Mbnl1ΔE3/ΔE3 hearts were explanted onto collagen gels. The number of explants per group is indicated. An asterisk indicates
a significant difference from wild type (P≤ 0.05). d Conditioned supernatants were collected from E9 wild type and Mbnl1ΔE3/ΔE3 AVC explants and the
levels of active TGFβ proteins secreted into the media were assayed by ELISA
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had more invaded cells than wild type explants. In chick,
the effects of MBNL1 knockdown are temporally regu-
lated, such that knockdown of MBNL1 induces increased
invasion in stage 14 AVC explants, but has no significant
effect in stage 16 AVC explants [20]. Likewise, the number
of invaded cells in AVC explants from E9.5 Mbnl1ΔE3/ΔE3
mice was similar to that of wild type E9.5 explants (Fig. 2c).
Thus, both the stimulatory effect of loss of MBNL1 on
EMT and its temporal regulation are conserved between
birds and mammals.
In chick stage 14 AVC explants, elevated levels of active
TGFβ3, but not TGFβ2, are secreted into the medium fol-
lowing MBNL1 knockdown [20]. In chick, TGFβ3 is re-
quired for invasion of mesenchymal cells, whereas TGFβ2
is required for endocardial cell activation [32]. TGFβ
signaling is also important for endocardial cushion
EMT in mammals, but with some differences in ligand
specificity [7–9]. To determine whether the levels of ac-
tive TGFβ secreted by Mbnl1ΔE3/ΔE3 AVC cushions dif-
fered from those of wild type, we collected conditioned
media from wild type and Mbnl1ΔE3/ΔE3 AVC explants
and measured the levels of active TGFβ1, TGFβ2, and
TGFβ3 by enzyme-linked immunosorbent assay (ELISA)
(Fig. 2d). There was a trend towards higher levels of all
three TGFβ proteins, but differences did not reach statis-
tical significance. This may be attributable in part to the
detection limits of the assay, as the measured levels of
TGFβ proteins were very low, and we failed to detect any
TGFβ in some supernatants from both wild type and
Mbnl1ΔE3/ΔE3 explants.
Loss of MBNL1 leads to precocious EMT and TGFβ
signaling in the endocardial cushions in vivo without a
persistent increase in total mesenchyme production
In chick stage 14 AVC explants, knockdown of MBNL1
stimulates precocious and elevated levels of active TGFβ3
secreted into the medium, and early exposure to elevated
TGFβ3 levels is sufficient to induce precocious invasion
[20]. The level of invasion induced at the earlier stage by
loss of MBNL1 is similar to that of control explants from
the later stage in both chick and mouse [20], consistent
with an accelerated induction of invasion. EMT normally
begins in the mouse AVC cushions at E9.5 [33], and in-
deed no invaded cells were observed in heart sections
from wild type embryos at E9.25 (Fig. 3a). In contrast,
histological analysis of Mbnl1ΔE3/ΔE3 embryos revealed the
presence of invaded cells within the AVC cushions already
at E9 (Fig. 3b), suggesting that MBNL1 prevents preco-
cious mesenchyme formation both ex vivo and in vivo. To
determine whether TGFβ signaling is precociously acti-
vated in Mbnl1ΔE3/ΔE3 AVC cushions in vivo, we per-
formed immunohistochemistry using an antibody against
phosphorylated SMAD2 (pSMAD2), a mediator of canon-
ical TGFβ signaling. In wild type hearts, high pSMAD2
levels were seen in a small number of AVC cushion endo-
cardial cells at E9.25 (Fig. 3c). In Mbnl1ΔE3/ΔE3 hearts
pSMAD2 was strongly detected in nearly all cells in the
AVC endocardium (as well as the invaded mesen-
chyme) by E9 (Fig. 3d), resembling pSMAD2 staining in
wild type hearts at E10 (data not shown). This indicates
that the precocious production of invasive mesenchyme
in the absence of MBNL1 is accompanied by preco-
cious TGFβ signaling.
To determine whether the precocious induction of in-
vasion leads to an over-production of cushion mesen-
chyme in vivo, the numbers of invaded cells in the AVC
cushions were counted in serial sections from E10.5 wild
type and Mbnl1ΔE3/ΔE3 embryos (Fig. 3e-g). Despite the
early initiation of EMT in Mbnl1ΔE3/ΔE3 AVC cush-
ions, there was no significant difference in the relative
amount of AVC mesenchyme once EMT is well un-
derway (P = 0.34). Imaging of E10.5 hearts using op-
tical coherence tomography (OCT) confirmed that
Mbnl1ΔE3/ΔE3 AVC cushions are indeed similar in size
and shape to wild type (Fig. 3h, i and Additional file 2:
Movie S1 and Additional file 3: Movie S2). Overt differ-
ences in cushion cellularity were also not observed in sec-
tions of wild type and Mbnl1ΔE3/ΔE3 hearts at E11.5, E12.5,
or E14.5 (data not shown). Thus, although MBNL1 re-
stricts the timing of EMT initiation in the AVC cushions,
it is not essential for regulating the total amount of mes-
enchyme produced in vivo.
Loss of MBNL1 has little effect on EMT in the AVC
cushions at E10.5
At E10.5, abundant pSMAD2 staining is seen through-
out the endocardium and mesenchyme of both wild
type and Mbnl1ΔE3/ΔE3 AVC cushions (data not shown).
To evaluate EMT-associated gene expression in the
Mbnl1ΔE3/ΔE3 AVC cushions at this stage, the levels of
84 genes that either change their expression during
EMT or that regulate gene expression changes during
EMT were assessed by real-time RT-PCR on total RNA
from wild type or Mbnl1ΔE3/ΔE3 E10.5 AVC cushions
using Epithelial to Mesenchymal Transition RT2 Pro-
filer PCR Arrays (Additional file 4: Table S1). TGFβ
transcript levels were not affected (Fig. 4a), although it
should be noted that increases in the levels of active
TGFβ3 secreted by chick AVC explants following
MBNL1 knockdown occurred without an accompany-
ing increase in TGFB3 transcript levels [20]. Consistent
with equivalent amounts of mesenchyme production,
both endothelial markers such as versican (Vcan) and
E-cadherin (Cdh1), which are down-regulated during
EMT, and mesenchymal markers such as fibronectin
(Fn1) and matrix metallopeptidase 2 (Mmp2), which
are up-regulated during EMT, did not differ between
wild type and Mbnl1ΔE3/ΔE3 cushions. Important
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Fig. 3 Mbnl1EΔ3/ΔE3 mice have precocious EMT in the endocardial cushions without a persistent increase in total mesenchyme production. Close-
up views of the hearts in sagittal sections of wild type E9.25 (a) and Mbnl1ΔE3/ΔE3 E9 (b) embryos stained with H&E reveal precocious invasion of
mesenchymal cells (red arrowhead) into the AVC cushions of knockout mice. Sections from three individuals were evaluated for each group;
representative images are shown. Close-up views of the AVC cushions in adjacent sections from wild type E9.25 (c) and Mbnl1ΔE3/ΔE3 E9 (d)
embryos subjected to immunohistochemistry with an antibody against pSMAD2 reveal high levels of TGFβ signaling in only a few cells in wild
type cushions (red arrowhead), but nearly all cells in the knockout cushions. H&E stained sagittal sections of wild type (e) and Mbnl1ΔE3/ΔE3 (f)
hearts do not reveal noticeable hypercellularity in the AVC cushions at E10.5. Atr = atrium, vent = ventricle, EC = endocardial cushion, OFT =
outflow tract. g The average relative number of mesenchymal cells was determined by counting the cells within the AVC cushions on serial,
H&E-stained, sagittal sections of wild type and Mbnl1ΔE3/ΔE3 E10.5 embryos. Representative three-dimensional reconstructions of AVC cushions
from optical sections of wild type (h) and Mbnl1ΔE3/ΔE3 (i) E10.5 hearts imaged using optical coherence tomography. Videos of the optical sections and
reconstructions of these hearts are shown in Additional file 2: Movie S1 and Additional file 3: Movie S2, respectively; still images shown here
were rotated to the same viewing angle
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transcriptional regulators of EMT such as Snai1, Snai2
(Slug), and Twist1 also do not differ between wild type
and Mbnl1ΔE3/ΔE3 cushions. Only four genes (Zeb1,
Mitf, Bmp7, and Spp1) differed significantly between
wild type and Mbnl1ΔE3/ΔE3 cushions by at least two-
fold (Fig. 4b, c). Zinc-finger E-box binding homeobox
1 (ZEB1), a transcription factor that interacts with ac-
tivated SMAD proteins to promote EMT in response
to TGFβ signaling [34], is down-regulated more than
three-fold. Microphthalmia-associated transcription factor
(MITF), which negatively regulates SMAD-dependent
TGFβ signaling in mast cells [35], is up-regulated approxi-
mately two-fold. Bone morphogenetic protein 7 (Bmp7)
levels are also doubled in Mbnl1ΔE3/ΔE3 cushions. While
neither Bmp7 nor Bmp6 alone are essential for endocar-
dial cushion development, double-knockout mice lacking
both Bmp7 and Bmp6 exhibit delayed formation of the
OFT cushions and defects in valve morphogenesis [36]. Fi-
nally, the glycoprotein secreted phosphoprotein 1 (Spp1),
also known as osteopontin, is elevated more than
three-fold. Transcription of Spp1 is induced by both
TGFβ and BMP signaling [37], so its up-regulation
could be due to elevated TGFβ signaling or to the
up-regulation of BMP7 or both. Repression of Spp1 is
required for prevent matrix mineralization in the de-
veloping heart valves [38], and elevated SPP1 levels
are associated with calcific valve disease in mice and
humans [39–41]. Thus, while these results suggest
that TGFβ signaling is precociously activated in the
Mbnl1ΔE3/ΔE3 cushions, it is unclear whether elevated
TGFβ signaling is maintained once EMT is underway.
Unfortunately, the small size and lack of cellularity in
the cushions at E9-9.5 makes collecting enough AVC
cushion tissue for a similar analysis during the initi-
ation of EMT untenable.
Heart valve morphogenesis is aberrant in fetal Mbnl1ΔE3/ΔE3
hearts
The continued expression of MBNL1 in the endocardial
cushions and heart valves at post-EMT stages (Fig. 1f-h)
suggests that MBNL1 may play additional roles in heart
valve development beyond regulating the timing of the
onset of EMT. Transformation of the endocardial cush-
ions into the heart valves is a complex process involving
expansion and condensation of the mesenchyme, differen-
tiation of mesenchymal cells into valve interstitial cells,
and changes in the composition and organization of the
extracellular matrix [2, 3, 5]. Heart valve remodeling in
the mouse occurs between E10.5 and E18.5. To deter-
mine whether heart valve morphogenesis is altered in
Mbnl1ΔE3/ΔE3 mice, we compared the three-dimensional
structures of fetal valves in E19.5 wild type and
Mbnl1ΔE3/ΔE3 hearts using OCT. We chose to focus on
the pulmonary valve because this valve is the most ac-
cessible at E19.5 for imaging by this method. In the
E19.5 wild type heart, the pulmonary valve is globular
(Fig. 5a and Additional file 5: Movie S3). Although the
boundaries of the individual leaflets cannot be resolved
due to their tight apposition, three distinct lobes
roughly aligned in the same plane are readily appreci-
ated. In contrast, in the E19.5 Mbnl1ΔE3/ΔE3 heart, the
pulmonary valve is highly dysmorphic and its leaflets
are not aligned within a single horizontal plane (Fig. 5b
and Additional file 6: Movie S4).
Next, the pulmonary, aortic, mitral, and tricuspid
valves were compared in sections from wild type and
Fig. 4 Epithelial to Mesenchymal Transition RT2 Profiler PCR Arrays reveal few changes in gene expression in Mbnl1EΔ3/ΔE3 AVC cushions at E10.5.
a-c) The expression of genes involved in EMT was compared in E10.5 wild type and Mbnl1ΔE3/ΔE3 AVC endocardial cushions using the Epithelial to
Mesenchymal Transition RT2 Profiler PCR Array (Qiagen). a Tgfb1, Tgfb2, and Tgfb3 transcript levels in the knockout cushions did not differ from
wild type. b Clustered heat map of transcripts that showed a ≥ 2 fold change in Mbnl1ΔE3/ΔE3 cushions with P≤ 0.05. c Transcript levels of the four
genes that showed a ≥ 2 fold change in Mbnl1ΔE3/ΔE3 cushions. An asterisk indicates significant difference from wild type (P≤ 0.05). Error bars
represent 95 % confidence intervals
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Fig. 5 (See legend on next page.)
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(See figure on previous page.)
Fig. 5 Loss of MBNL1 leads to valve dysmorphia in the fetal heart. Three-dimensional representations of the pulmonary valve at E19.5 reconstructed
from optical sections of a representative wild type (a) and three different Mbnl1ΔE3/ΔE3 (b) hearts imaged using optical coherence tomography. Videos
of the optical sections and reconstructions of the wild type heart in (a) and the leftmost of the Mbnl1ΔE3/ΔE3 hearts in (b) are shown in Additional file 5:
Movie S3 and Additional file 6: Movie S4, respectively. Representative high magnification views of the pulmonary (c, d), aortic (f, g), mitral (i, j),
and tricuspid (l, m) valves of E18.5 wild type (c, d, i, l) and Mbnl1ΔE3/ΔE3 (d, g, j, m) heart sections stained with hematoxylin and eosin. Yellow asterisks
indicate eosinophilic tissue connecting the valve leaflets to the vessel or chamber wall. Nearby sections through the pulmonary (e), aortic (h), mitral
(k), and tricuspid (n) valves of the Mbnl1ΔE3/ΔE3 hearts shown in (d, g, j, m) were stained with Movat’s pentachrome stain. Scale bars in panels C-N
represent 100 μm
Fig. 6 Loss of MBNL1 leads to changes in matrix composition and TGFβ signaling in the heart valves. a High magnification view of the septal
leaflet of the tricuspid valve on a coronal section of an adult Mbnl1ΔE3/ΔE3 heart stained with Masson’s trichrome reveals swellings of collagen-poor
tissue in the valve (black arrowhead). The inset shows the corresponding valve leaflet in a wild type heart. Histological analysis was performed on
sections from both male and female wild type (n = 7) and knockout (n = 12) mice ranging in age from 4 to 15 months. Representative images shown
are from 5 month-old mice. b High magnification view of the mural leaflet of the tricuspid valve on a coronal section of an adult Mbnl1ΔE3/ΔE3 heart
stained with Movat’s pentachrome reveals normal stratification but reduced mucin staining indicative of glycosaminoglycans in the regions of
swelling. The inset shows a comparable wild type leaflet. Movat’s pentachrome staining was performed on heart sections from three mice for
each group ranging from 10 to 15 months old; representative images shown are from 15 month-old mice. c Western blot analysis confirms
loss of MBNL1 protein, and shows a decrease in chondroitin sulfate proteoglycans (CSPG) and increases in fibronectin, phosphorylated SMAD2
(pSMAD2), and MBNL2 in Mbnl1ΔE3/ΔE3 heart valves compared to wild type. Protein integrity and loading were also confirmed by Ponceau S
staining (data not shown). Representatives of three independent sets using samples from 5–6 month-old male mice are shown. d Transcript
levels in Mbnl1ΔE3/ΔE3 heart valves were compared to those of wild type heart valves by real-time RT-PCR (n = 5 to 6 each, ~10 month-old
males). e Accumulations of fibronectin (red arrowheads) were seen in the Mbnl1ΔE3/ΔE3 tricuspid valve by immunohistochemistry. The inset
shows a tricuspid valve leaflet from a wild type heart. Immunohistochemistry was performed on heart sections from three mice for each group
ranging from 4 to 10 months old; representative images shown are from 4 month-old mice
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Mbnl1ΔE3/ΔE3 E18.5 hearts by histology (Fig. 5c-n). In
four of eight Mbnl1ΔE3/ΔE3 E18.5 hearts, but none of
three wild type hearts, anucleate, eosinophilic tissue con-
necting the valve leaflets to the vessel or chamber wall
was observed in one or more valves by hematoxylin and
eosin staining (Fig. 5 and data not shown). In nearby
sections, this eosinophilic connective tissue stained bright
red with Movat’s pentachrome stain, indicative of fibrin.
Consistent with the OCT results, apparent misalignment
of valve leaflets was also seen to a variable degree in
Mbnl1ΔE3/ΔE3, but not wild type, hearts. Thus, in the ab-
sence of MBNL1 the remodeling of the endocardial cush-
ions into the heart valves is aberrant in the fetal heart.
Loss of MBNL1 results in changes in the matrix
composition and TGFβ signaling in adult heart valves
Histological analysis also revealed valve dysmorphia in
adult Mbnl1ΔE3/ΔE3 mice. Whereas wild type inflow
valves stain predominantly blue with Masson’s trichrome
stain due to their high collagen content, collagen-poor
swellings sparsely populated with small, unstained, stel-
late cells were seen in some sections from Mbnl1ΔE3/ΔE3
hearts (Fig. 6a). Although these swellings occurred in
both the mitral and tricuspid valves, they were larger
and more common in the tricuspid valve. These swell-
ings are reminiscent of those seen in periostin-null
mice [42], although other defects characteristic of
periostin-null valves such as loss of collagen, failure of
delamination, and improper remodeling of the associ-
ated myocardium were not observed. In the mature
valve, the ECM is stratified into three highly organized
layers: the collagen-rich fibrosa, proteoglycan-rich
spongiosa, and elastin-rich atrialis (or ventricularis in
the outflow valves) [43]. Although this stratification ap-
pears relatively normal in the Mbnl1ΔE3/ΔE3 valves by
Movat’s pentachrome staining, there is reduced mucin
staining in the spongiosa layer in the regions of the
swellings, indicative of a loss or dilution of the proteo-
glycans in these sites (Fig. 6b). Using an antibody
against chrondroitin sulfate, lower levels of total chon-
droitin sulfate proteoglycan (CSPG) expression were
observed in Mbnl1ΔE3/ΔE3 valves (Fig. 6c). When CSPG
transcript levels were compared by real time RT-PCR,
however, aggrecan, versican, decorin, and biglycan
showed no difference, whereas brevican and neurocan
were actually higher in Mbnl1ΔE3/ΔE3 valves (Fig. 6d). It
is possible that the apparent loss of CSPGs in the
Mbnl1ΔE3/ΔE3 valves is due to reduced production or at-
tachment of the sulfated glycosaminoglycan side chains
to the core proteins rather than a decline in proteogly-
can expression per se. The ECM protein fibronectin is
highly expressed in the endocardial cushions and valve
precursors, but is down-regulated during maturation
[44, 45]. Although fibronectin transcript levels did not
differ between wild type and Mbnl1ΔE3/ΔE3 cushions at
E10.5 (Additional file 4: Table S1), fibronectin transcript
levels were elevated in adult Mbnl1ΔE3/ΔE3 valves by
real-time RT-PCR (Fig. 6d). Elevated levels of fibronec-
tin protein were also seen in adult Mbnl1ΔE3/ΔE3 valves
by western blot (Fig. 6c), and accumulations of fibro-
nectin were seen in the tricuspid valve by immunohis-
tochemistry (Fig. 6e).
Western blot analyses also revealed higher levels of
pSMAD2 in adult Mbnl1ΔE3/ΔE3 valves compared to
wild type (Fig. 6c), indicating elevated levels of TGFβ
signaling in the adult valves. Unlike precocious activa-
tion of TGFβ signaling in the endocardial cushions, this
is accompanied by an up-regulation of Tgfb1, though
not Tgfb2 or Tgfb3, mRNA levels in the knockout
valves (Fig. 6d).
Loss of MBNL1 leads to valve regurgitation and atrial
septal defects
To determine whether heart valve function is compro-
mised by loss of MBNL1, transthoracic echocardiog-
raphy was performed on approximately 22 week old wild
type and Mbnl1ΔE3/ΔE3 mice. Color-flow and 2D-pulsed
Doppler revealed a high incidence of regurgitation across
the pulmonary, aortic, and mitral valves in Mbnl1ΔE3/ΔE3
mice (Table 1 and Additional file 7: Figure S2); blood flow
across the tricuspid valve was not assessed. In contrast, no
regurgitation was observed across the aortic or mitral
valves in wild type mice. Although mild regurgitation
was observed across the pulmonary valve in some
wild type animals, it was less common and less severe
than that observed in the knockout animals (Table 1
and data not shown).
In addition to regurgitation, atrial communication was
observed in several of the Mbnl1ΔE3/ΔE3 mice, but only
one of their wild type counterparts, by color and pulsed
Doppler (Table 1 and Additional file 7: Figure S2). Ana-
tomical dissection of male and female mice ranging in
age from 10 weeks to one year-old confirmed the pres-
ence of a patent foramen ovale in 50 % of Mbnl1ΔE3/ΔE3
Table 1 Incidence of valve regurgitation and atrial
communication in wild type versus Mbnl1ΔE3/ΔE3 hearts as
assessed by echocardiography
na %PRa %ARa %MRa %ACa
Wild type males 6 83 0 0 17
Wild type females 4 25 0 0 0
Wild type, total 10 60 0 0 10
Mbnl1ΔE3/ΔE3 males 5 80 80 80 40
Mbnl1ΔE3/ΔE3 females 4 100 75 100 75
Mbnl1ΔE3/ΔE3, total 9 89 78 89 56
an number of animals evaluated, PR pulmonary regurgitation, AR aortic valve
regurgitation, MR mitral valve regurgitation, AC atrial communication
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hearts, but less than 10 % of wild type hearts (Fig. 7a
and Table 2). Even when successfully closed, the foramen
ovale was noticeably enlarged in some Mbnl1ΔE3/ΔE3
hearts, but not in wild type (Fig. 7b and Table 2). Since
atrial communication would not occur in these cases,
however, there is unlikely to be any functional defect.
Closure of the foramen ovale occurs in mice within the
first week of postnatal life when the septum primum
fuses with the septum secundum [46, 47]. When exam-
ined at late fetal stages, the foramen ovale was markedly
enlarged in sections of some Mbnl1ΔE3/ΔE3 hearts
(Fig. 7c-d). The infolding of the atrial roof at the super-
ior margin (septum secundum) and the flap valve (de-
rived from the septum primum) appear normal in these
hearts, but the muscular base of the primary atrial
septum where the flap valve is anchored appears re-
duced. Ostium secundum defects can result from either
a failure to fully form the septum secundum, or from a
failure of the septum primum to cover the entire oval
fossa [47]. This histological analysis suggests the latter,
not the former, is the reason for the high incidence of
foramen ovale patency and atrial communication in the
knockout mice. In other fetal Mbnl1ΔE3/ΔE3 hearts, the
foramen ovale and its associated structures look similar
to wild type (data not shown). No other septal defects
were observed in wild type or knockout hearts.
Although MBNL1 is also expressed in the myocardium
(Fig. 1), myocardial dysfunction has not been observed
in Mbnl1ΔE3/ΔE3 mice. Lee and colleagues reported that
Mbnl1ΔE3/ΔE3 hearts perform similarly to wild type in
echocardiographic and electrocardiographic tests of
muscle function [48]. We also evaluated myocardial
function in Mbnl1ΔE3/ΔE3 mice by M-mode echocardiog-
raphy of 8 week old mice (Table 3). Although slight in-
creases in anterior and posterior wall thickness were
observed during diastole, there were no differences dur-
ing systole. There was a trend towards small reductions
in ejection fraction and fractional shortening (to ~90 %
of wild type values), but these did not reach statistical
significance, consistent with previous reports [48]. Total
heart size, measured either as a percentage of total body
weight or as heart weight normalized to tibia length, also
did not differ between wild type and Mbnl1ΔE3/ΔE3 mice
at four months of age (Table 4).
It has previously been reported that the closely related
paralog, MBNL2, can compensate for loss of MBNL1 in
the myocardium. MBNL2 protein levels are elevated in
Fig. 7 Mbnl1EΔ3/ΔE3 mice exhibit ostium secundum atrial septal defects. a The heart of a one year-old adult Mbnl1ΔE3/ΔE3 mouse is shown with the
atrial appendages removed. Patency of the foramen ovale is demonstrated by the unobstructed passage of a coarse bristle. b Excision of the atrial
septum from adult hearts shows failure of the foramen ovale to close in some Mbnl1ΔE3/ΔE3 mice (left), while the foramen ovale is closed but enlarged
in others (right). Representative images of the wild type and patent Mbnl1ΔE3/ΔE3 foramen ovales shown are from 10 month-old mice; the image of the
closed, but enlarged, foramen ovale is from a 2.5-month old Mbnl1ΔE3/ΔE3 mouse. Compared to a wild type counterpart (c), the foramen
ovale (bracketed by the green lines) is enlarged in an E19.5 Mbnl1ΔE3/ΔE3 heart (d) as shown in close-ups of coronal sections stained with
Masson’s trichrome. SS = septum secundum, FV = flap valve, FO = foramen ovale
Table 2 Incidence of foramen ovale defects in wild type versus
Mbnl1ΔE3/ΔE3 hearts as assessed by gross dissection
na PFOa eFOa
Wild type males 7 0 0
Wild type females 17 12 0
Wild type, total 24 8 0
Mbnl1ΔE3/ΔE3 males 4 50 25
Mbnl1ΔE3/ΔE3 females 16 50 25
Mbnl1ΔE3/ΔE3, total 20 50 25
an number of animals evaluated, PFO patent foramen ovale, eFO enlarged, but
closed, foramen ovale
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the hearts of Mbnl1ΔE3/ΔE3 mice [48]. MBNL1 and
MBNL2 recognize similar RNA elements [49, 50], and
MBNL2 binding to MBNL targets increases when
MBNL1 is absent [48]. Restoring MBNL2 to near wild
type levels in Mbnl1-null mice by removal of one Mbnl2
allele was sufficient to induce atrial dilation, ventricular
hypertrophy, and conduction defects [48]. In these com-
pound knockout mice MBNL2 levels were assessed in
whole heart, however, leaving it unclear whether MBNL2
was elevated specifically within the myocardium, which
comprises the majority of the heart by volume, or in all
cells that normally express MBNL1. We tested whether
loss of MBNL1 results in increased MBNL2 levels within
the heart valves by western blot and real-time RT-PCR
(Fig. 6c, d). We found that MBNL2 protein levels were
higher in Mbnl1ΔE3/ΔE3 valves, although Mbnl2 tran-
script levels remained unchanged, suggesting post-
transcriptional regulation at the level of translation or
protein stability. Thus, the up-regulation of MBNL2 is
not restricted to muscle tissue. The presence of valve
dysmorphia and regurgitation in Mbnl1ΔE3/ΔE3 mice,
however, indicates that unlike in the myocardium,
higher levels of MBNL2 are insufficient to fully com-
pensate for loss of MBNL1 in the heart valves.
Pigmentation is increased in Mbnl1ΔE3/ΔE3 heart valves
During dissection and collection of heart valves from
adult wild type and Mbnl1ΔE3/ΔE3 hearts, we observed a
greater amount of pigment in valves from the knockout
mice (Fig. 8). The presence of cardiac melanocytes in
murine heart valves has been well documented [51–56].
Lineage tracing studies have demonstrated that these
melanocytes are derived from invading neural crest cells,
and normally populate the tricuspid, mitral, and aortic
valves, but not the pulmonary valve [53, 55]. We saw an
increase in the presence of pigmentation in both inflow
and outflow valves in Mbnl1ΔE3/ΔE3 hearts, including one
instance of pigment in the pulmonary valve (Fig. 8a-c).
In order to compare the amount of pigment in wild type
and Mbnl1ΔE3/ΔE3 valves, we developed a pigmentation
scoring system (Additional file 8: Figure S3) in which
each valve was given a score of 0 (no melanin) to 3
(abundant melanin). In addition to an increased inci-
dence of pigmentation, we also saw an increase in the
amount of pigment within pigmented valves (Fig. 8d).
The level of pigmentation has been shown to correlate
with coat color in mice [55]. All of our wild type and
Mbnl1ΔE3/ΔE3 mice are on the B6129 background, a hy-
brid of C57BL/6 black mice and 129 albino mice, and
have either brown or black coats. The incidence and
relative amount of pigmentation in wild type or
Mbnl1ΔE3/ΔE3 valves were the same regardless of coat
color (data not shown), so data from brown and black
mice were pooled in the graphs in Fig. 8. Despite these
differences in pigmentation, wild type and Mbnl1ΔE3/ΔE3
valves express similar levels of dopachrome tautomerase
(DCT), a marker of the melanoblast lineage found in
melanocytes and their precursors, and tyrosinase related
protein 1 (TYRP1), a marker of differentiated melano-
cytes (Fig. 8e).
Discussion
The present study demonstrates that MBNL1 is required
for normal heart valve development and function.










Heart rate (beats/min) 491.6 ± 21.7 512.7 ± 22.2 0.25 482.2 ± 38.7 488.7 ± 21.2 0.44
Anterior wall thickness, diastole (mm) 0.43 ± 0.02 0.48 ± 0.02 0.04* 0.43 ± 0.02 0.49 ± 0.03 0.03*
Anterior wall thickness, systole (mm) 0.57 ± 0.03 0.60 ± 0.02 0.18 0.53 ± 0.03 0.54 ± 0.02 0.40
LV diameter, diastole (mm) 3.96 ± 0.16 4.17 ± 0.16 0.18 3.79 ± 0.10 3.70 ± 0.06 0.25
LV diameter, systole (mm) 2.43 ± 0.13 2.75 ± 0.22 0.12 2.31 ± 0.15 2.38 ± 0.06 0.33
LV posterior wall thickness, diastole (mm) 0.52 ± 0.02 0.52 ± 0.03 0.49 0.46 ± 0.02 0.55 ± 0.03 0.03*
LV posterior wall thickness, systole (mm) 0.56 ± 0.02 0.58 ± 0.04 0.31 0.53 ± 0.01 0.55 ± 0.01 0.19
Ejection fraction (%) 75.3 ± 1.8 69.4 ± 4.1 0.11 75.8 ± 2.8 72.1 ± 1.2 0.14
Fractional shortening (%) 38.6 ± 1.6 34.7 ± 3.4 0.16 39.4 ± 2.4 35.9 ± 1.0 0.11
* Significant difference (P < 0.05) from wild type










Percentage of body weight 0.52 ± 0.02 0.53 ± 0.04 0.39 0.46 ± 0.02 0.51 ± 0.03 0.10
Heart weight/tibia length (mg/mm) 9.72 ± 0.49 9.13 ± 0.59 0.22 6.44 ± 0.12 7.12 ± 0.42 0.07
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Mbnl1ΔE3/ΔE3 mice, which lack MBNL1 protein, have
valve dysmorphia, alterations in ECM composition, and
regurgitation across both inflow and outflow valves. Loss
of MBNL function has been implicated in the pathogen-
esis of myotonic dystrophy (dystrophia myotonica, DM), a
multisystemic genetic disorder characterized by a number
of cardiac, muscle, endocrine, and neurological defects
[57]. DM is caused by the expression of mutant RNAs
containing expanded CUG (DM1) or CCUG (DM2) re-
peats, which leads to the dysregulation of other transcripts
in part through the sequestration of MBNL proteins (for a
detailed review of DM pathogenesis see [57]). Notably,
DM patients exhibit a variety of cardiac abnormalities, in-
cluding a high incidence of mitral valve prolapse [58].
Mbnl1ΔE3/ΔE3 mice recapitulate many of the features of
DM, including skeletal muscle myotonia and cataracts
[59], but a valve phenotype had not previously been de-
scribed. Valve dysfunction in DM patients has generally
been assumed to be a consequence of myopathy, caused
by weakness of the papillary muscles to which the inflow
valves connect [58]. Although Mbnl1ΔE3/ΔE3 mice do not
exhibit overt cardiomyopathy, loss of MBNL1 function in
the papillary muscles could predispose the mice to tricus-
pid and mitral valve failure. This would not explain differ-
ences in function of the aortic and pulmonary valves in
Mbnl1ΔE3/ΔE3 mice, however, which are free standing. The
expression of both MBNL1 and MBNL2 in wild type adult
heart valves argues instead for a direct function of MBNL
proteins in heart valve homeostasis. Suggestively, MBNL2
is one of sixteen genes within a locus on chromosome 13
that has been genetically linked with mitral valve prolapse
[60], although to date no studies have corroborated a role
for MBNL2 in valve disease. Both nuclear and cytoplasmic
Fig. 8 Mbnl1ΔE3/ΔE3 heart valves exhibit increased valve pigmentation.
a A top view of a 10 month-old adult Mbnl1ΔE3/ΔE3 heart with the
major vessels and atrial appendages removed is shown. Pigment can
be seen in all four valves of this heart. TC = tricuspid valve, mit =mitral
valve, ao = aortic valve, pulm = pulmonary valve. b The accumulation
of pigment is readily apparent in a representative high magnification
view of the mitral valve on an unstained coronal section of a
10 month-old adult Mbnl1ΔE3/ΔE3 heart. c The percentage of each
valve with visible pigment was calculated for wild type (n = 26)
and Mbnl1ΔE3/ΔE3 (n = 16) hearts from male and female mice
ranging from 2.5 to 10 months old. No differences were observed
between the sexes. d The extent of pigmentation was compared
for each valve using a scoring system of 0 (no melanin) to 3
(abundant melanin) in the hearts from (c); see Additional file 8:
Figure S3 for examples. An asterisk indicates a significant difference
from wild type (P ≤ 0.05). e Western blots analysis shows no
difference in the expression of melanocyte markers in wild type
versus Mbnl1ΔE3/ΔE3 heart valves. Each lane represents a pool of all
four valves (tricuspid, mitral, aortic, and pulmonary) from one
individual. A representative of two blots (n = 2 or 3 independent
samples on each blot from 5–6 month-old males) is shown. Protein
integrity and equivalent loading were confirmed by Ponceau S
staining (data not shown)
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roles of MBNL proteins have been implicated in DM
pathogenesis, including regulation of pre-mRNA alterna-
tive splicing, alternative polyadenylation, microRNA bio-
genesis, mRNA localization and stability [22, 24, 25, 29]. It
remains to be determined which of these roles are essen-
tial in the developing valves.
We previously showed that knockdown of MBNL1 in
chicken endocardial cushion explants enhanced auto-
crine TGFβ3 and invasive mesenchyme production ex
vivo in a stage-dependent manner [20, 21]. Here, we
demonstrate that loss of MBNL1 has a similar effect in
mouse endocardial cushion explants ex vivo. In chick ex-
plants, activation (i.e., separation of cells from the endo-
thelial monolayer) and invasion (migration into the
collagen gel) are easily distinguishable steps of EMT; un-
fortunately, in mouse endocardial cushion explants acti-
vation is not readily apparent, as cells appear to invade
directly from the explant into the collagen gel [13].
Thus, although we saw a stage-dependent increase in
the number of invaded cells in Mbnl1ΔE3/ΔE3 explants,
we cannot say whether invasion per se is specifically
stimulated as we observed in the chick [20, 21]. Loss of
MBNL1 stimulates precocious TGFβ signaling and EMT
in mouse endocardial cushions in vivo, which is also
consistent with our previous finding that knockdown of
MBNL1 in chick endocardial cushion explants stimulates
precocious secretion of active TGFβ3 in vitro [20]. This
effect is temporary in the mice, however, as the amount
of total mesenchyme produced is normalized by E10.5,
and few changes in EMT gene expression are observed
at this stage. Taken together, these data suggest that
MBNL1 regulates the initiation of EMT, but not its pro-
gression. The dysmorphia and presence of abnormal
connective tissue in the fetal valves indicates a develop-
mental role for MBNL1 in valvulogenesis; if not regulat-
ing the amount of cushion mesenchyme, then perhaps
influencing its fate during valve maturation.
The stratification of the adult valve suggests that matrix
remodeling is relatively unimpaired in Mbnl1ΔE3/ΔE3 mice.
The presence of collagen/proteoglycan-poor swellings
sparsely populated with stellate cells, however, indicates
localized increases in matrix with an atypical composition.
Indeed, while CSPGs levels are reduced, the ECM protein
fibronectin is strongly up-regulated. The maintenance of
stratification and the specific changes in ECM compos-
ition observed in the adult Mbnl1ΔE3/ΔE3 valves are not
characteristic of either myxomatous valve degeneration or
calcific valve disease. The persistence of fibronectin in
adult Mbnl1ΔE3/ΔE3 valves could be indicative of incom-
plete or defective differentiation of the cushion mesen-
chyme in the knockout mice. MBNL1 has recently been
shown to regulate alternative splicing changes that are im-
portant for stem cell differentiation [61, 62], and MBNL1
has been implicated in the differentiation of skeletal
muscle, blood, lens, and adipose cells [63–67]. Alterna-
tively, elevated fibronectin expression in the adult valves
could be indicative of injury to the valves, perhaps due to
changes in shear stress caused by altered valve biomech-
anics. Valve interstitial cells have been shown to up-
regulate fibronectin in response to injury in primary cul-
tures [68]. The accumulation of fibronectin in the adult
valve may in turn then have a detrimental effect on valve
function by altering the valve’s elasticity or stiffness.
The higher levels of fibronectin in adult Mbnl1ΔE3/ΔE3
valves could also potentially have a protective effect. We
found that both Tgfb1 transcript levels and TGFβ signal-
ing (as indicated by pSMAD2) are elevated in the adult
knockout valves. Elevated TGFβ1 levels are associated
with calcification in stenotic valves, and addition of
TGFβ1 is sufficient to induce calcification in valve inter-
stitial cells in culture [69]. We have observed no signs of
overt calcification in Mbnl1ΔE3/ΔE3 valves, however, even
in animals as old as 90 weeks (data not shown). Notably,
fibronectin has been shown to protect cultured valve
interstitial cells from TGFβ1-induced calcification [70].
The mechanisms by which TGFβ1 and fibronectin are
up-regulated in adult Mbnl1ΔE3/ΔE3 valves, and the ex-
tent to which MBNL1 exerts its effects in the mature
valve through modulation of the ECM and/or TGFβ ac-
tivity, remain to be determined.
The relevance of increased pigmentation in the
Mbnl1ΔE3/ΔE3 heart valves is unclear. Pigmented cells
were first observed in the mouse heart over fifty years
ago [54]. Although gene expression profiling suggests
these cardiac melanocytes are more similar to cardiomyo-
cytes than canonical melanocytes found in the skin, these
neural crest-derived cells express melanocyte markers and
produce melanin in non-albino mice [51–53, 55, 56].
DCT-expressing cells have also been reported in human
heart valves, although these cells lack TYRP1 and are not
pigmented [56]. The purpose of these cells is not well
understood. One suggestion has been that the enzymes
within the melanin synthesis pathway buffer calcium and
reactive species in the heart [56]. Melanin is synthesized
from the amino acid tyrosine in a multistep process in
which DCT converts the intermediate dopachrome into
5,6-dihydroxyindole carboxylic acid (DHICA), which is
then converted into eumelanin by TYRP1 [71]. The nor-
mal levels of DCT and TYRP1 in the Mbnl1ΔE3/ΔE3 valves
suggests that the increase in pigmentation is not due to an
increase in the number of melanocytes in the valves, or an
up-regulation in these steps of melanin production. Little
is known about melanin turnover. The accumulation of
pigment in the heart valves is associated with stiffening of
the valves, regurgitation, and stenosis in patients with
alkaptonuria, a rare autosomal recessive disorder of tyro-
sine metabolism characterized by ochronosis, the accumu-
lation of pigment within the connective tissues [72–75].
Coram et al. BMC Developmental Biology  (2015) 15:36 Page 14 of 20
An ex vivo nanomechanical study of mouse tricuspid
valves reported that pigmented regions of the tricuspid
leaflet are stiffer than regions lacking pigment [76]. Thus,
increased pigment in the valves of Mbnl1ΔE3/ΔE3 mice
could contribute to their functional impairment by alter-
ing their biomechanical properties.
The impact of loss of MBNL1 in the heart is not con-
fined to the developing valves. Many Mbnl1ΔE3/ΔE3 mice
had ostium secundum defects. A strong association be-
tween ostium secundum defects and mitral valve pro-
lapse has been documented [77, 78]. Examination of the
fetal heart prior to closure revealed that the septum
secundum, which forms from infolding of the atrial roof
at the superior margin, and the septum primum, which
forms the flap valve, appear normal in the knockout
mice. The muscular base to which the flap valve is an-
chored, however, is smaller in some Mbnl1ΔE3/ΔE3 hearts.
The muscular base of the atrial septum arises from myo-
cardialization of mesenchyme within the dorsal mesen-
chymal protrusion (DMP), a derivative of the secondary
heart field, not the endocardial cushions [47]. Under-
development of the DMP can be caused by reduced
proliferation, increased apoptosis, or premature myo-
cardialization of the DMP mesenchyme [47]. Muta-
tions in several genes, including cardiac transcription
factors such as NKX2.5, GATA4, and TBX20, have
been linked to atrial septal defects and foramen ovale
patency in humans [79–81], but their precise roles in
the development and maturation of the DMP are not
known. Often, defects in the DMP are associated with
more severe atrioventricular septal defects, but these,
or other types of septal defects that arise from defect-
ive remodeling of the endocardial cushions, are not
observed in Mbnl1ΔE3/ΔE3 mice. Although atrial com-
munication can lead to right atrial overload and other
cardiac complications, stand-alone ostium secundum
defects are often clinically benign [47].
The lack of overt cardiomyopathy in Mbnl1ΔE3/ΔE3
mice despite both atrial communication and poor valve
function might initially be surprising, but it should be
noted that these mice also experience progressive skel-
etal muscle myotonia [59]. As Mbnl1ΔE3/ΔE3 mice age
and their myotonia worsens, their level of activity de-
creases, which may help reduce their cardiac burden.
The up-regulation of MBNL2 may also help the strained
heart muscle compensate [48]. It has also been reported,
however, that Mbnl1-knockout mice on a pure 129 sv
genetic background (as opposed to Mbnl1ΔE3/ΔE3 mice,
which are on a hybrid background of C57/BL6 and129
strains) exhibit progressive cardiac dysfunction, cardiac
hypertrophy, and myocardial cell death and fibrosis des-
pite a similar up-regulation of MBNL2 [82]. The differ-
ence in heart muscle pathogenesis between the mouse
strains suggests the existence of modifier genes that
modulate the function of MBNL1 in the heart. MBNL1-
dependent heart valve phenotypes have not been investi-
gated on a pure 129 background.
Conclusions
MBNL1 is highly expressed in the endocardial cushions
and heart valves. It plays a conserved role in regulating
the onset of TGFβ signaling and EMT in the endocardial
cushions, but is not essential for limiting the total
amount of cushion mesenchyme production in vivo.
Mice lacking MBNL1 exhibit defects in valve morpho-
genesis, ECM composition, function, and pigmentation,




Mouse studies were conducted in strict accordance
with the recommendations of the American Veterinary
Medical Association and under the approval of the
Cleveland Clinic Institutional Animal Care and Use
Committee (Protocols 2011–0547 and 2014–1201). All
efforts were made to minimize pain and distress during
mouse animal husbandry and euthanasia. Mbnl1ΔE3/ΔE3
mice have a targeted deletion of Mbnl1 exon 3, which
contains the canonical translation start codon, resulting
in loss of MBNL1 expression [59]. Mice were maintained
in a B6129 hybrid background. Embryos at specific stages
were obtained by timed mating. In general, midday follow-
ing observation of a copulation plug was considered em-
bryonic day 0.5 (E0.5). Stages of embryos collected from
E9 through E10.5 were confirmed by counting the number
of somites of each individual embryo (E9 = 19–20 somites,
E9.5 = 22–23 somites, E10.5 = 34–36 somites).
Immunohistochemistry and western blotting
For immunohistochemistry, whole embryos or postnatal
hearts were fixed overnight by immersion in 4 % para-
formaldehyde (embryonic stages) or 10 % neutrally buff-
ered formalin (adult), and then embedded in paraffin.
Immunohistochemistry was performed on 10 μm sec-
tions. The sections were immersed in xylene, rehydrated
through a 100 %, 95 %, and 80 % ethanol series, and
then washed in water. Antigen retrieval was performed
by boiling slides in citrate buffer (10 mM citric acid,
0.05 % Tween 20, at pH 6.0) for 30 min. The slides were
washed three times in 1x Tris-buffered saline (TBS) and
blocked in 3 % goat serum in 1x TBS for 1 h at room
temperature. The primary antibody was added at a 1:50
to 1:400 dilution and incubated overnight at 4 °C. The
slides were washed in TBS as before, incubated in 0.3 %
hydrogen peroxide for 30 min at room temperature, and
washed in 1x TBS. The secondary antibody was added at
a 1:400 dilution and incubated for one hour at room
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temperature. Slides were washed 3 times in 1X TBS and
developed using DAB Plus Substrate Kit (Invitrogen) ac-
cording to the manufacturer’s instructions. The slides
were dehydrated through a 25 %, 50 %, 75 %, and 100 %
ethanol series, cleared with xylene, and mounted with
Permount (Fisher Scientific). Negative controls lacking
primary antibody were performed in parallel for every
experiment.
Heart tissues were homogenized in protein loading
buffer and subjected to western blotting as previ-
ously described [30]. Protein integrity and equiva-
lent loading were verified by Ponceau S staining.
For western blots on adult heart valves, all four
valves (tricuspid, mitral, aortic, and pulmonary)
from one to three individuals were pooled together
for each sample. All westerns were performed on
three or more independent pooled samples from
each group.
Primary antibodies used for immunohistochemistry
and western blotting were: MBNL1 = rabbit poly-
clonal anti-MBNL1 (Aviva Systems Biology, catalog
number ARP41227_P050) for immunohistochemistry,
and mouse monoclonal anti-MBNL1, 3A4 [83] or
rabbit polyclonal anti-MBNL1, A2764 (generously
provided by Charles A. Thornton, University of
Rochester, NY) for western blotting; pSMAD2 =
rabbit polyclonal anti-phospho-Smad2 (Ser465/467)
(Cell Signaling Technology, catalog number 3101);
CSPG =mouse monoclonal anti-chondroitin sulfate,
CS-56 (Sigma, catalog number C8035); Fibronectin =
rabbit polyclonal anti-fibronectin (Sigma, catalog
number F3648); GAPDH =mouse monoclonal anti-
GAPDH, 6G5 (Biogenesis, catalog number 4699–
9555); DCT = goat polyclonal anti-TRP2, D-18 (Santa
Cruz, catalog number sc-10451); TYRP1 = rabbit poly-
clonal anti-TRP1, H-90 (Santa Cruz, catalog number
sc-25543); MBNL2 =mouse monoclonal anti-MBNL2,
3B4 (Santa Cruz, catalog number sc-136167). Secondary
antibodies used were: goat anti-rabbit-HRP (Calbiochem,
catalog number 401393); goat anti-mouse-HRP (Calbio-
chem, catalog number DC02L); donkey anti-goat-HRP
(Santa Cruz, sc-2056).
Explants
Collagen gels were prepared as previously described
[21]. Collagen gels were incubated in Hydration Medium
[Opti-MEM supplemented with 1 % each ITS (Invitro-
gen), fetal bovine serum, and pen/strep antibiotic solu-
tion] for 30 min at 37 °C prior to use, which was then
removed before explants were placed on the gel. The
AVC regions were excised from E9 or E9.5 embryos, cut
open, placed endothelial-side down on the collagen gels,
and incubated at 37 °C in 5 % CO2. After 12 h, Mouse
M199+ [M199 supplemented with 1 % each ITS
(Invitrogen), fetal bovine serum, and pen/strep antibiotic
solution] was added to each well. Explants were fixed
after 48 h of culture in 4 % paraformaldehyde for 45 min
at room temperature, and stored in PBS at 4 °C. Invaded
cells were counted on a Leica DMIRB microscope fitted
with Hoffman Modulation Contrast optics. Explants
were imaged using QCapture Pro 6.0 software.
For enzyme-linked immunosorbent assay (ELISA) ex-
periments, 200 μl of Mouse M199+ medium was added
to each explant at 12 h, and the conditioned medium
was collected at 48 h. Secreted active TGFβ levels in the
conditioned media were measured by sandwich ELISA
as previously described [20]. A pan-TGFβ antibody
(R&D Systems, catalog number MAB1835) was used for
capture, and a specific biotinylated anti-TGFβ1 (R&D
Systems, catalog number BAF240), anti-TGFβ2 (R&D
Systems, catalog number BAF302), or anti-TGFβ3 (R&D
Systems, catalog number BAF243) was used for detec-
tion. Serial dilutions of recombinant TGFβ1, TGFβ2,
and TGFβ3 (R&D Systems, catalog numbers 240-B-002,
302-B2, and 243-B3, respectively) were used to generate
standard curves.
Gene expression and alternative splicing
Total RNA was extracted using Trizol Reagent (Thermo
Scientific) and quantified using a NanoDrop 1000. Endo-
cardial cushions were dissected out of wild type and
Mbnl1ΔE3/ΔE3 E10.5 embryos by cutting open the heart
tube and separating the cushions from the underlying
myocardium using an electrolytically-sharpened tung-
sten needle [84]. Both the superior and inferior AVC
cushions were collected from each embryo, and the
cushions from 10–14 embryos (one to two litters) were
combined and treated as a single biological replicate.
Three such pooled samples were collected for each
group. The expression levels of 84 genes that either
change their expression during EMT or regulate gene
expression changes during EMT were assessed by real-
time RT-PCR using the Epithelial to Mesenchymal Tran-
sition RT2 Profiler PCR Array (Qiagen) according to the
manufacturer’s instructions. Transcript levels were nor-
malized to Gusb; similar results were obtained when
data were normalized against Gapdh (data not shown).
Error bars represent 95 % confidence intervals.
For gene expression changes in adult heart valves, each
sample represents a pool of all four heart valves (tricus-
pid, mitral, aortic, and pulmonary) from a single individ-
ual. Transcript levels were determined by real-time RT-
PCR using SYBR Green Master Mix (Applied Biosys-
tems) and normalized to Gapdh as previously described
[85]. Primer sequences for aggrecan, versican, brevican,
neurocan, decorin, bigylcan, and scleraxis were taken
from Barnette et al. [86]; sequences of the remaining
primers are shown in Table 5. Samples from five to six
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individuals per group were each run in triplicate. Error
bars represent standard error of the mean values for the
biological replicates.
Histology
Whole embryos or postnatal hearts were fixed overnight
by immersion in 4 % paraformaldehyde (embryonic
stages) or 10 % neutrally buffered formalin (adult). Fixed
embryos or hearts were embedded in paraffin, sectioned,
and stained with hematoxylin and eosin (H&E), Mas-
son’s trichrome, or Movat’s pentachrome stain. To deter-
mine the relative number of mesenchymal cells at E10.5,
10 μm sections were taken through the entire heart,
those sections containing AVC cushions were identified,
and six sections taken 10 μm apart (every other section)
from the center of the AVC region were stained with
H&E, imaged on a Leica DM 2500 microscope using
QCapture Pro 6.0 software, and counted. Invaded
cells were counted in the cushions of four embryos
per group.
Optical coherence tomography (OCT)
Wild type and Mbnl1ΔE3/ΔE3 embryos were collected at
E10.5 (n = 10 and 6, respectively) or E19.5 (n = 3 each),
fixed overnight in 4 % paraformaldehyde, dehydrated
through a 25, 50, 75, 100 % methanol series in PBSw
(PBS with 0.1 % Tween-20), and stored in 100 % metha-
nol at −20 °C. Embryos were later rehydrated through a
100, 75, 50, 25 % methanol series in PBSw followed by
transfer into PBS. The hearts were removed under a dis-
secting microscope. E19.5 hearts were cleared prior to
imaging using the ClearT method described for whole
dissected brains (E16-P11) [87], which has also been
used for embryonic day 8 quail embryo hearts [88], to
improve penetration depth. Embryos were imaged using
a custom-built Fourier domain OCT system with a quasi-
telecentric scanner, linear-in-wavenumber spectrometer
and a line-scan camera with a line rate of 47 kHz [89, 90].
The axial resolution as well as the lateral resolution
is approximately 10 μm in tissue. Thus OCT imaging
offers high spatial resolution and good penetration
depth (1–3 mm in cardiac tissues) for phenotyping
embryonic hearts [91]. Custom MATLAB programs
(MathWorks; Natick, MA) were utilized to create
OCT images from the raw data. Amira software (FEI
Visualization Sciences Group; Burlington, MA) was
used to visualize OCT data.
Heart function and size
Cardiac structural and functional changes were assessed
in vivo by echocardiography performed on age- and sex-
matched wild type and Mbnl1ΔE3/ΔE3 mice anesthetized
with isofluorane gas (1-2 % with 2 lpm oxygen) using a
GE Vivid7 Ultrasound system equipped with a 14 MHz
iL13 probe. Two-dimensional and M-mode echocardio-
graphic measurements of the anterior wall, posterior
wall, and left ventricular diameter were recorded in the
parasternal short axis view of the left ventricle at the
level of the papillary muscles. Modified short-axis views
were recorded to assess the possibility of atrial or ven-
tricular septal defects, and to obtain pulmonary, aortic,
and mitral valve Doppler flow measurements. Functional
parameters were calculated using standard formulas
[92]. To control for differences in body size, heart size
was evaluated both as the percentage of total body
weight that is heart weight and as a ratio of heart weight
to tibia length.
Statistics
Data are reported as the mean + standard error of the
mean unless otherwise noted. Comparisons between
means were performed via t-test assuming unequal vari-
ances. Comparisons between proportions were performed
Table 5 qRT-PCR primer sequences used in this study
Gene Forward (F) and Reverse (R) primer sequences Product size (bp)
Fibronectin F: CAGATGCAACGATCAGGACAC 272
R: CAGATCCGGCTGAAGCACTTT
Tgfb1 F: ATACGCCTGAGTGGCTGTCT 123
R: AGTGAGCGCTGAATCGAAAG
Tgfb2 F: CTGGAACCACTGACCATTCTC 131
R: CGTGATTTTCGTGTCCTGGC
Tgfb3 F: TGAATGGCTGTCTTTCGATG 102
R: GTGACATGGACAGTGGATGC
Mbnl2 F: CCCCGTGAGAGACACAAAGTG 235
R:CCTCCCATTAATCTCTAGCTGG
Gapdh F: TCGTCCCGTAGACAAAATGG 132
R: TTGAGGTCAATGAAGGGGTC
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via z-test. Differences were considered statistically signifi-
cant when P ≤ 0.05.
Additional files
Additional file 1: Figure S1. MBNL1 expression in the embryonic brain.
Immunohistochemistry with an anti-MBNL1 antibody was performed on
sagittal sections from E9 wild type mouse embryos. Close-up of the head
shows strong MBNL1 expression in the ectoderm lining the entrance to
Rathke’s pouch (Rp), forebrain (FB), midbrain (MB), and hindbrain (HB)
with little to no detectable staining within the interior encephalic tissues
(highlighted by asterisks). A representative section from one of four
embryos is shown. (PDF 1247 kb)
Additional file 2: Movie S1. Imaging of the AVC cushions in a
representative wild type heart at E10.5 by OCT. Optical sections through
a representative E10.5 wild type heart are shown. The AVC cushions are
highlighted in purple, and a three-dimensional reconstruction of the AVC
cushions is shown. A still image of this 3D reconstruction is shown in
Fig. 3h, but has been rotated and scaled to match the orientation and
magnification of the Mbnl1ΔE3/ΔE3 image in Fig. 3i. (MOV 2333 kb)
Additional file 3: Movie S2. Imaging of the AVC cushions in a
representative Mbnl1ΔE3/ΔE3 heart at E10.5 by OCT. Optical sections
through a representative E10.5 Mbnl1ΔE3/ΔE3 heart are shown. The AVC
cushions are highlighted in purple, and a three-dimensional reconstruction
of the AVC cushions is shown. A still image of this 3D reconstruction is
shown in Fig. 3i. (MOV 1197 kb)
Additional file 4: Table S1. Epithelial to Mesenchymal Transition RT2
Profiler PCR Array data for Mbnl1ΔE3/ΔE3 versus wild type E10.5 AVC
cushions. (XLS 42 kb)
Additional file 5: Movie S3. Imaging of the pulmonary valve in a
representative wild type heart at E19.5 by OCT. A three-dimensional
reconstruction of a representative wild type E19.5 heart is shown with
the pulmonary valve highlighted in purple, followed by optical sections
through the heart. The pulmonary valve is indicated in purple, and a
three-dimensional reconstruction of the valve is shown. A still image of this
3D reconstruction is shown in Fig. 5a. (MOV 3438 kb)
Additional file 6: Movie S4. Imaging of the pulmonary valve in a
representative Mbnl1ΔE3/ΔE3 heart at E19.5 by OCT. A three-dimensional
reconstruction of a representative Mbnl1ΔE3/ΔE3 E19.5 heart is shown with
the pulmonary valve highlighted in purple, followed by optical sections
through the heart. The pulmonary valve is indicated in purple, and a
three-dimensional reconstruction of the valve is shown. A still image of
this 3D reconstruction is shown in Fig. 5b. (MOV 3542 kb)
Additional file 7: Figure S2. Color and pulsed Doppler ultrasound
revealed valve regurgitation and atrial communication in Mbnl1EΔ3/ΔE3
mice. (A) Sequential color Doppler ultrasound images show regurgitation
across the aortic valve of an Mbnl1ΔE3/ΔE3 mouse. Arrows indicate the
direction of blood flow. LV = left ventricle, Ao = aorta, AV = aortic valve.
Pulsed Doppler ultrasound revealed regurgitation across Mbnl1ΔE3/ΔE3 (B)
pulmonary, (C) aortic, and (D) mitral valves. Arrows indicate regurgitation
peaks. Atrial communication was observed in some Mbnl1ΔE3/ΔE3 mice by
(E) color and (F) pulsed wave Doppler ultrasound. RA = right atrium,
LA = left atrium, RV = right ventricle, LV = left ventricle. (PDF 8654 kb)
Additional file 8: Figure S3. Scoring system for heart valve
pigmentation. To evaluate the extent of pigmentation of the valves, a
scoring system was developed in which each valve was given a score of
0 (no melanin), 1 (sparse melanin), 2 (moderate melanin), or 3 (abundant
melanin). Representative inflow and outflow valves for each category are
shown. (PDF 3893 kb)
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